hVIVO plc (LON:HVO – Get Free Report)’s share price was up 9.9% during mid-day trading on Monday . The stock traded as high as GBX 21.50 ($0.27) and last traded at GBX 21.24 ($0.26). Approximately 2,611,591 shares changed hands during trading, a decline of 2% from the average daily volume of 2,672,759 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Stock Up 9.7 %
The stock has a market cap of £144.24 million, a P/E ratio of 706.67 and a beta of 0.97. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The business has a 50-day simple moving average of GBX 20.36 and a 200-day simple moving average of GBX 25.73.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Read More
- Five stocks we like better than hVIVO
- Stock Sentiment Analysis: How it Works
- MP Materials: Rare Earth Elements Powering the EV Boom
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- High Flyers: 3 Natural Gas Stocks for March 2022
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
